About
Marshall Hayward, Ph.D., is a co-founder, Chief Scientific Officer, and director of Jupiter Neurosciences, a clinical-stage neuroinflammation company. Public company disclosures describe more than 30 years of pharmaceutical R&D experience, including prior roles at EffRx Pharmaceuticals, Hurley Consulting Associates, SmithKline Beecham, Johnson & Johnson, and Ayerst/Wyeth. He appears to be a scientist-executive with a meaningful equity stake in Jupiter rather than a professional investor or fund operator.
Areas of interest
biotechneurosciencealzheimer's diseaserare disease drug developmentneuroinflammationpharmaceutical R&Ddrug commercialization